Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL Brilliance

The M/A I understand. This is what I don't get:

" -get bought... as part of the settlement MATSUSHITA buys PTSC for X times PPS on a certain (past or future) date - which is more to PHOLs ideals.

On what facts are you basing your idea that there will be a buy-out?

Share
New Message
Please login to post a reply